Group 1 - Cencora (COR) is a notable stock in the Medical sector, currently outperforming the sector with a year-to-date return of 29.6% compared to an average loss of 5.3% for the Medical group [4][5] - Cencora holds a Zacks Rank of 2 (Buy), indicating positive analyst sentiment and an improving earnings outlook, with a 2.9% increase in the consensus estimate for full-year earnings over the past 90 days [3] - The Medical group ranks 4 within the Zacks Sector Rank, which includes 16 different groups, highlighting the relative strength of this sector [2] Group 2 - Cencora is part of the Medical Services industry, which consists of 58 stocks and currently ranks 68 in the Zacks Industry Rank, with an average loss of 3.9% year-to-date [5] - Catalyst Pharmaceutical (CPRX), another stock in the Medical sector, has also outperformed the sector with a year-to-date return of 19.6% and holds a Zacks Rank of 2 (Buy) [4][6] - The Medical - Drugs industry, which includes Catalyst Pharmaceutical, ranks 55 and has experienced a decline of 1.8% so far this year [6]
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?